HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Zhao Selected Research

MAP Kinase Kinase Kinase 1

3/2022Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).
2/2016MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Zhao Research Topics

Disease

179Neoplasms (Cancer)
10/2022 - 04/2005
61Breast Neoplasms (Breast Cancer)
06/2022 - 11/2006
37Inflammation (Inflammations)
09/2022 - 03/2003
28Neoplasm Metastasis (Metastasis)
01/2022 - 04/2005
21Infections
06/2022 - 12/2006
19Carcinogenesis
01/2022 - 01/2012
18Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 10/2012
17Hypoxia (Hypoxemia)
06/2022 - 10/2005
16Stomach Neoplasms (Stomach Cancer)
04/2022 - 05/2008
16Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2003
14Ovarian Neoplasms (Ovarian Cancer)
07/2022 - 01/2012
13Carcinoma (Carcinomatosis)
01/2021 - 04/2005
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2010
12Body Weight (Weight, Body)
01/2020 - 12/2002
11Prostatic Neoplasms (Prostate Cancer)
01/2022 - 04/2011
10Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 12/2012
9Wounds and Injuries (Trauma)
07/2022 - 04/2006
8Pain (Aches)
12/2021 - 11/2011
8Insulin Resistance
10/2021 - 01/2010
8Hypertension (High Blood Pressure)
01/2021 - 02/2007
8Lymphatic Metastasis
01/2020 - 08/2007
8Myocardial Infarction
01/2020 - 02/2008
7Neuroinflammatory Diseases
10/2022 - 12/2019
7Fibrosis (Cirrhosis)
11/2021 - 01/2015
7Non-alcoholic Fatty Liver Disease
10/2021 - 03/2016
7Lung Neoplasms (Lung Cancer)
01/2021 - 02/2012
7Heart Failure
01/2021 - 11/2006
6Sepsis (Septicemia)
09/2022 - 10/2015
6COVID-19
12/2021 - 01/2020
6Spinal Cord Injuries (Spinal Cord Injury)
04/2021 - 10/2010
6Glioma (Gliomas)
04/2021 - 12/2012
6Cataract (Cataracts)
01/2021 - 04/2009
6Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 02/2008
6Obesity
01/2020 - 12/2012
5Mitochondrial Diseases (Mitochondrial Disease)
06/2022 - 08/2014
5Fanconi Anemia (Fanconi's Anemia)
05/2022 - 01/2012
5Hyperplasia
01/2022 - 05/2006
5Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 03/2008
5Hemorrhage
01/2022 - 06/2009
5Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 01/2018
5Cardiotoxicity
01/2022 - 01/2018
5Tourette Syndrome (Tourette's Syndrome)
03/2021 - 08/2012
5Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 06/2015

Drug/Important Bio-Agent (IBA)

62Proteins (Proteins, Gene)FDA Link
08/2022 - 03/2006
51Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2013
29MicroRNAs (MicroRNA)IBA
01/2022 - 01/2010
28Pharmaceutical PreparationsIBA
07/2022 - 04/2008
25Messenger RNA (mRNA)IBA
12/2021 - 11/2003
19DNA (Deoxyribonucleic Acid)IBA
05/2022 - 08/2007
17Long Noncoding RNAIBA
01/2022 - 04/2018
16CytokinesIBA
02/2022 - 12/2012
12LipidsIBA
12/2021 - 01/2014
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2021 - 05/2009
10LipopolysaccharidesIBA
10/2022 - 10/2015
10Doxorubicin (Adriamycin)FDA LinkGeneric
06/2022 - 05/2013
10Small Interfering RNA (siRNA)IBA
08/2019 - 01/2012
9Biological ProductsIBA
08/2022 - 07/2016
9Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2015
9RNA (Ribonucleic Acid)IBA
06/2022 - 01/2019
9ErbB Receptors (EGF Receptor)IBA
05/2022 - 03/2010
9EnzymesIBA
04/2022 - 01/2010
8Caspase 3 (Caspase-3)IBA
07/2022 - 07/2014
8HMGB1 Protein (HMG1)IBA
03/2022 - 12/2012
8Phosphotransferases (Kinase)IBA
01/2021 - 03/2011
8FebuxostatFDA Link
01/2011 - 03/2005
7Immune Checkpoint InhibitorsIBA
10/2022 - 01/2020
7Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 12/2014
7Fatty Acids (Saturated Fatty Acids)IBA
04/2022 - 01/2010
7Oncogene Proteins (Oncogene Protein)IBA
01/2022 - 12/2016
7Indicators and Reagents (Reagents)IBA
01/2021 - 09/2013
7CateninsIBA
12/2020 - 01/2019
7LigandsIBA
12/2020 - 06/2013
7Xanthine OxidaseIBA
11/2008 - 03/2005
6IronIBA
06/2022 - 11/2008
6Hormones (Hormone)IBA
06/2022 - 08/2014
6Circular RNAIBA
01/2022 - 01/2019
6AntioxidantsIBA
01/2022 - 12/2012
6Interleukin-6 (Interleukin 6)IBA
01/2022 - 10/2016
6Therapeutic UsesIBA
12/2021 - 12/2010
6SodiumIBA
12/2021 - 12/2002
6Peptides (Polypeptides)IBA
04/2021 - 01/2012
6Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2019 - 05/2008
6Estrogen ReceptorsIBA
02/2019 - 05/2008
5Uric Acid (Urate)IBA
11/2022 - 01/2008
5Triglycerides (Triacylglycerol)IBA
08/2022 - 04/2008
5SolutionsIBA
04/2022 - 12/2002
5Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 05/2008
5InterleukinsIBA
12/2021 - 05/2013
5Insulin (Novolin)FDA Link
11/2021 - 04/2008
5Androgen Receptors (Androgen Receptor)IBA
01/2021 - 02/2016
5purineIBA
01/2021 - 03/2005
5ningdongIBA
09/2020 - 08/2011

Therapy/Procedure

76Therapeutics
08/2022 - 01/2006
30Drug Therapy (Chemotherapy)
07/2022 - 03/2003
15Immunotherapy
08/2022 - 01/2012
12Radiotherapy
01/2022 - 01/2010
8Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 08/2009
7Neoadjuvant Therapy
10/2019 - 11/2006
6Length of Stay
02/2022 - 06/2009
6Transplantation
01/2022 - 12/2006